SpaceX's extreme valuation at nearly 100 times revenue carries significant risk, reminiscent of the 2021 tech bubble.
Government bureaucracy is slowing down funding and approvals for critical national security projects, such as domestic antimony production.
The increasing autonomy of AI agents in high-stakes environments poses significant financial and safety risks if not properly monitored.
The potential for a large-scale employee sell-off after the IPO lockup period could create downward pressure on SpaceX's stock.
Opportunities Identified
United States Antimony Corp. is uniquely positioned as the sole-source supplier to the U.S. government amid a global supply crunch.
The emerging market for AI agent monitoring and reliability platforms presents a new investment frontier in the AI ecosystem.
The massive demand for the SpaceX IPO from institutional and sovereign wealth funds indicates strong market appetite for high-growth, AI-focused companies.
The joint venture to create a fully domesticated antimony production line in the U.S. represents a long-term strategic asset.